There is considerable evidence that hearing and vestibular function can be influenced by immune processes. The inner ear has evolved mechanisms, such as the blood -labyrinthine barrier that limit immune responses and autoimmune processes to reduce the potential for damage to cochlear cells. Recently, expression of Fas ligand (FasL) in some non-lymphoid tissue, as in the anterior chamber of the eye, has been hypothesized to play a role in protection of sensitive organs from activated T-cells. We show that under resting conditions, cochlear cells express little or no FasL. However, after exposure to interferon-g in vitro, FasL is induced in many neonatal cochlear cells. In addition, we show that FasL is upregulated in adult cochlear cells after induction of a sterile labyrinthitis in vivo. The induction of FasL by inflammation may serve to limit cochlear immune responses, and to protect sensorineural tissue from immune and autoimmune damage. D
Introduction
The FasL -Fas cell-to-cell signaling system plays a crucial role in a variety of biological processes, including development and tissue homeostasis, through the induction of programmed cell death. This system also plays a specific role in immune cytotoxicity, immune cell homeostasis and autoimmunity (Siegel et al., 2000) . FasL is a trimeric type II membrane protein of approximately 37 kDa and belongs to the TNF superfamily (Suda and Nagata, 1994; Suda et al., 1993; Takahashi et al., 1994) . Its receptor, Fas is a 319-amino acid type I transmembrane glycoprotein with an 80-amino acid region, the death domain, that serves as a module for protein -protein interaction and is critical for apoptosis signaling (Itoh et al., 1991; Tartaglia et al., 1993) . When FasL binds to Fas on target cells, caspases are activated and the cells die by programmed cell death (Nagata and Golstein, 1995; Suda et al., 1995) .
The Fas death receptor is expressed by many cell types, including most lymphocytes and inflammatory cells. However, as one would expect, expression of FasL is tightly regulated. FasL is expressed strongly on activated T-cells and NK cells, where it participates in killing of infected or neoplastic cells, and in the deletion of autoreactive T-cells (Suda et al., 1995; Bossi and Griffiths, 1999) . However, recently a growing number of non-lymphoid cells have been shown to express FasL. For example, cells in the anterior chamber of the eye (Griffith et al., 1995) and Sertoli cells of the testis (Bellgrau et al., 1995) constitutively express FasL. The FasL -Fas system plays an essential role in the eye, as mice which express a nonfunctional Fas receptor display ocular inflammation with inflammatory infiltrates in the choroid and sclera (Jabs and Prendergast, 1991; Jabs et al., 1996) . Constitutive FasL expression has been suggested to be involved in protection of immune-privileged sites from immune-mediated damage (Griffith et al., 1995; Griffith et al., 1996; Green and Ferguson, 2001) .
There is considerable evidence that hearing and vestibular function can be influenced by immune and autoimmune processes (Ma et al., 2000; Rahman et al., 2001; Ryan et al., 2001) . Although the immune system can protect the inner ear, immune-related inflammatory responses can also be 0165-5728/02/$ -see front matter D 2002 Elsevier Science B.V. All rights reserved. PII: S 0 1 6 5 -5 7 2 8 ( 0 2 ) 0 0 1 4 3 -1
